Hadassah

Hadassah Physician Advocates Successfully for Insurance Coverage of Medicine to Save Infant

Monday, Jan 30 2017

Prof. Shimon Reif, head of the Department of Pediatrics at Hadassah Hospital Ein Kerem.

Prof. Shimon Reif, head of the Department of Pediatrics at Hadassah Hospital Ein Kerem, successfully advocated for health insurance coverage of a medicine that a two-month-old baby with a rare metabolic disease needed to survive.

The baby’s genetic condition leads to her inability to metabolize fats. As Prof. Reif recently explained on Israeli radio, orphan diseases like this rarely have cures and when they do, the costs are very high because the medicine will only be needed for a small number of patients. The cost of this enzyme therapy called Kanuma is half a million shekels a year.

Appearing in the first weeks of life, the disease, called lysosomal acid lipase deficiency, impacts all bodily systems. The child experiences digestive and liver problems and fails to grow and is expected to live only a few months without the medication.

The Jerusalem baby's two older sisters, who were born with the same disease, both died. "This baby was brought to us when she was two months old," relates Prof. Reif. "Because of the terrible family history, we immediately did genetic testing."

Although the health basket committee had discussed approval of this medicine in October, at the time, there were no cases in Israel. “We thank God for the decision,” said the baby’s father. “We hope our daughter will now be able to grow and develop."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Dec 8 2017

Listening Beyond Eight Seconds

How long does the average doctor give a patient to tell her or him what’s wrong?

READ MORE ›
alt_text

Friday, Dec 8 2017

Israeli Start-Up Partners with Health Industry Leaders to Enhance Assessment of Head Trauma

MedyMatch Technology, an Israeli startup that has developed an artificial intelligence-based software to help clinicians more accurately assess head trauma or stroke...

READ MORE ›
alt_text

Wednesday, Dec 6 2017

Hadassah’s Globally Renowned Ophthalmologist Receives International Recognition

Prof. Yaacov Pe’er, Immediate Past Director of the Hadassah Medical Organization’s Ophthalmology Department, has been honored with the American Academy of Ophthalmology (AAO)’s annual prize for his contributions to the field of ophthalmology and the prevention of blindness around the world.

READ MORE ›
alt_text

Wednesday, Dec 6 2017

Hadassah and Australia Research Institute Sign MOU to Collaborate

A Memorandum of Understanding (MOU) to cooperate on scientific research in the fields of cardiovascular and diabetes medicine was signed on August 31 between the Hadassah Medical Organization and the Baker Heart and Diabetes Research Institute in Melbourne, Australia.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More